Cardio Flow
MN - St. PaulBiotechnology
Focus: Cardio Flow develops minimally invasive devices for peripheral artery disease, operating as a private biotech company focused on the cardiovascular device market.
Profile data last refreshed 1h ago · AI intelligence enriched 2w ago
Funding Stage
PRIVATE
Open Jobs
0
About Cardio Flow
AI assessmentNot HiringNo open roles listed right now. Follow Cardio Flow to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Cardio Flow FreedomFlow™ Orbital Atherectomy System treatment
Peripheral Arterial DiseaseClinical Trials (1)
NCT03365154Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat Peripheral Artery Disease (PAD)
N/AHelp build intelligence for Cardio Flow
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.